Track topics on Twitter Track topics that are important to you
MADISON HEIGHTS, Mich., Aug. 4, 2017 /PRNewswire/ -- InfuSystem Holdings, Inc. (NYSE MKT: INFU), a leading national provider of infusion pumps and related services for the U.S. healthcare industry, today announced that it will issue second quarter 2017 financial results on Wednesday, August 9, 2017, after the market close.
The Company will also conduct a conference call for all interested investors on Wednesday, August 9, 2017, at 4:30 p.m. Eastern Time to discuss second quarter 2017 financial results. To participate in this call, please dial in toll-free 1 (800) 446-2782 and use the confirmation number 45427320.
A replay of the call will be available via the Company's website for 90 days following the call at http://ir.infusystem.com/.
About InfuSystem Holdings, Inc.
InfuSystem Holdings, Inc. is a leading provider of infusion pumps and related services to hospitals, oncology practices and other alternate site healthcare providers. Headquartered in Madison Heights, Michigan, the Company delivers local, field-based customer support and also operates Centers of Excellence in Michigan, Kansas, California, Texas, Georgia and Ontario, Canada. The Company's stock is traded on the NYSE MKT under the symbol INFU. Additional information about InfuSystem Holdings, Inc. is available at www.infusystem.com.
Joe Dorame, Joe Diaz & Robert Blum
Lytham Partners, LLC
View original content with multimedia:http://www.prnewswire.com/news-releases/infusystem-to-issue-second-quarter-2017-financial-results-on-wednesday-august-9-2017-after-the-market-close-300499947.html
SOURCE InfuSystem Holdings, Inc.NEXT ARTICLE
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...